tirzepatide weight loss clinical trial Tirzepatide's Surmount-4 Reveals Groundbreaking Results Cardiovascular outcomes of semaglutide and

The mechanisms linking obesity to erectile dysfunction are multifactorial: Endothelial dysfunction : Excess adipose tissue promotes inflammation and impairs the function of blood vessel linings, reducing blood flow to the penis Hormonal imbalances : Obesity is associated with reduced testosterone levels and increased oestrogen, which can negatively impact sexual function Cardiovascular disease : Obesity increases the risk of atherosclerosis, hypertension, and other vascular conditions that compromise erectile function Metabolic syndrome : The cluster of conditions including insulin resistance, dyslipidaemia, and hypertension associated with obesity all contribute to erectile difficulties Psychological factors : Body image concerns, depression, and reduced self-esteem related to obesity can affect sexual confidence and performance Weight loss has been shown to improve erectile function in numerous studies

How do GLP-1s aid in medical weight loss

Knowledge about genetic testing enables you to make well-informed decisions regarding your health

Weight Loss Medication Risks and Benefits GLP-1 agonists and other weight-loss drugs offer real benefits but also carry meaningful risks